Reducing Vaccine Hesitancy among Hispanic Parents of COVID-19 Vaccine-Eligible Children

NIH Pandemic-Era Grants

Pandemic Era Grants

2023

Document text

Principal Investigator: Sunny Wonsun Kim
Organization: ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
Fiscal Year: 2023
Award: $419,796
Funding agency: Eunice Kennedy Shriver National Institute of Child Health and Human Development

Project Summary/Abstract
COVID-19 vaccines, currently available to children over six months old, are a powerful method of preventing
new infections and reducing the risk of hospitalization and death due to COVID-19. However, vaccination rates
among Hispanic children remain suboptimal. Lower vaccination rates in children are largely due to parental
vaccine hesitancy. While national health communication experts have suggested using storytelling as an
effective intervention strategy to promote COVID-19 vaccination, we will take the innovative next steps of
creating and evaluating a digital storytelling intervention to reduce Hispanic parental vaccine hesitancy.
Working with community health workers, we will engage Hispanic parents and legal guardians who report
being previously hesitant to vaccinate their child(ren) against COVID-19 to serve as our digital storytellers.
We will ask them to share their stories of conversion in COVID-19 vaccine perspectives to help other
parents and legal guardians overcome their unique concerns and mistrust of COVID-19 vaccines. Guided by
the Theory of Planned Behavior and storytelling as culture-centric health promotion, we propose to (Aim 1)
develop culturally-relevant digital stories (each 2-3 minutes long) with a diverse sample of Hispanic parents
and legal guardians who transformed from being COVID-19 vaccine-hesitant to vaccine-accepting. In Aim 2,
we will assess the feasibility and acceptability of a web-based pilot digital storytelling intervention vs.
information-only control among parents and legal guardians (n=80) of children who are not up-to-update with
COVID-19 vaccine doses. We will also explore pre- to post-intervention changes in vaccine perceptions,
vaccine hesitancy, intentions to vaccinate children against COVID-19, and children’s vaccine uptake at two-
month post-intervention. If our study demonstrates feasibility, acceptability, promising reductions in vaccine
hesitancy, and increases in vaccine uptake, we will conduct a full-scale randomized controlled trial to examine
the effectiveness of the DST intervention to reduce COVID-19 vaccine hesitancy in our target population. This
more extensive study could be used in future DST interventions to increase immunizations (e.g., flu, HPV)
among Hispanic children and adolescents. In addition, our innovative research may provide evidence of
scalable, disseminatable strategies to reduce vaccine hesitancy and can be used for other rapid vaccination
efforts for potential future outbreaks.

Terms: <0-11 years old><2 arm RCT><2 arm randomized control trial><2 arm randomized controlled trial><2019 novel corona virus><2019 novel coronavirus><2019-nCoV><2019-nCoV vaccine><Address><Adolescent><Adolescent Youth><Area><Attitude><Behavior><Belief><COVID-19><COVID-19 associated death><COVID-19 associated fatality><COVID-19 associated mortality><COVID-19 death><COVID-19 fatality><COVID-19 induced death><COVID-19 induced fatality><COVID-19 induced mortality><COVID-19 mortality><COVID-19 related death><COVID-19 related fatality><COVID-19 related mortality><COVID-19 vaccination><COVID-19 vaccine><COVID-19 virus><COVID19><COVID19 associated death><COVID19 associated fatality><COVID19 associated mortality><COVID19 death><COVID19 fatality><COVID19 induced death><COVID19 induced fatality><COVID19 induced mortality><COVID19 mortality><COVID19 related death><COVID19 related fatality><COVID19 related mortality><COVID19 vaccination><COVID19 vaccine><COVID19 virus><CV-19><CV19><Cessation of life><Child><Child Youth><Childhood><Children (0-21)><CoV-2><CoV2><Collaborations><Communities><Community Health Aides><Control Groups><Death><Disease><Disorder><Dose><Educational workshop><Elements><Eligibility><Eligibility Determination><Emotional><Family><Feasibility Studies><Focus Groups><Future><HPV><Health><Health Promotion><Health behavior><Hispanic><Hospital Admission><Hospitalization><Human Papilloma Virus><Human Papillomavirus><Immunity><Immunization><Individual><Infection><Infectious Human Wart Virus><Inflammatory><Influentials><Intervention><Intervention Strategies><Legal Guardians><Long COVID><Long COVID-19><Long coronavirus disease><Long coronavirus disease 2019><Methods><NICHD><National Institute of Child Health and Human Development><National Institute of Children's Health and Human Development><Non-Hispanic><Nonhispanic><Not Hispanic or Latino><On-Line Systems><Online Systems><Parents><Participant><Pattern><Perception><Persuasion><Persuasive Communication><Planning Theory><Population><Protocol Screening><Public Health><Randomized, Controlled Trials><Recommendation><Reporting><Research><Risk Reduction><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 associated death><SARS-CoV-2 associated fatality><SARS-CoV-2 associated mortality><SARS-CoV-2 death><SARS-CoV-2 fatality><SARS-CoV-2 induced death><SARS-CoV-2 induced fatality><SARS-CoV-2 induced mortality><SARS-CoV-2 mortality><SARS-CoV-2 related death><SARS-CoV-2 related fatality><SARS-CoV-2 related mortality><SARS-CoV-2 vaccination><SARS-CoV-2 vaccine><SARS-CoV2><SARS-CoV2 vaccine><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 vaccine><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Salutogenesis><Sampling><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 vaccine><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 vaccination><Severe acute respiratory syndrome coronavirus 2 vaccine><Severe acute respiratory syndrome related corona virus 2><Social Perception><Syndrome><System><Target Populations><Testing><Transportation><Update><Vaccinated><Vaccination><Vaccines><Virus><Work><Workshop><Wuhan coronavirus><accept vaccination><accept vaccine><acceptability and feasibility><access to vaccination><access to vaccines><arm><assess effectiveness><chronic COVID><chronic COVID-19><chronic novel coronavirus disease 2019><community engagement><community health worker><corona virus disease 2019><corona virus disease 2019 vaccine><coronavirus disease 2019><coronavirus disease 2019 associated death><coronavirus disease 2019 associated fatality><coronavirus disease 2019 associated mortality><coronavirus disease 2019 death><coronavirus disease 2019 fatality><coronavirus disease 2019 induced death><coronavirus disease 2019 induced fatality><coronavirus disease 2019 induced mortality><coronavirus disease 2019 mortality><coronavirus disease 2019 related death><coronavirus disease 2019 related fatality><coronavirus disease 2019 related mortality><coronavirus disease 2019 vaccination><coronavirus disease 2019 vaccine><coronavirus disease 2019 virus><coronavirus disease-19><coronavirus disease-19 mortality><coronavirus disease-19 vaccine><coronavirus disease-19 virus><coronavirus infectious disease-19><cost><death due to COVID-19><death due to COVID19><death due to SARS-CoV-2><death due to coronavirus disease 2019><death due to severe acute respiratory syndrome coronavirus 2><death in COVID><death in COVID-19><death in SARS-CoV-2><death in coronavirus disease><death in coronavirus disease 2019><death in severe acute respiratory syndrome coronavirus 2><design><designing><determine effectiveness><digital><effective intervention><effectiveness assessment><effectiveness evaluation><ethnic minority><evaluate effectiveness><examine effectiveness><experience><fatality due to COVID-19><fatality due to COVID19><fatality due to SARS-CoV-2><fatality due to coronavirus disease 2019><fatality due to severe acute respiratory syndrome coronavirus 2><flu><future outbreak><hCoV19><health communication><health related behavior><hesitant to vaccination><improved><innovate><innovation><innovative><insight><intervention cost><interventional strategy><juvenile><juvenile human><kids><long haul COVID><long haul COVID-19><long haul coronavirus disease><long haul coronavirus disease 2019><long-hauler COVID><long-hauler COVID-19><long-hauler coronavirus disease 2019><long-hauler syndrome><long-term COVID><long-term COVID-19><long-term coronavirus disease><long-term coronavirus disease 2019><longterm COVID><longterm COVID-19><longterm coronavirus disease><longterm coronavirus disease 2019><member><mortality due to COVID-19><mortality due to COVID19><mortality due to SARS-CoV-2><mortality due to coronavirus disease 2019><mortality due to severe acute respiratory syndrome coronavirus 2><nCoV vaccine><nCoV-19 vaccine><nCoV19 vaccine><nCoV2><next outbreak><online computer><pandemic><pandemic disease><parent><pediatric><post COVID syndrome><post COVID-19 syndrome><post acute COVID syndrome><post acute COVID-19><post acute COVID-19 syndrome><post acute SARS-CoV-2><post acute coronavirus disease 2019><post acute coronavirus disease 2019 syndrome><post acute coronavirus disease syndrome><post acute severe acute respiratory syndrome coronavirus 2><post coronavirus disease 2019 syndrome><post coronavirus disease syndrome><post intervention><post-acute phases of COVID-19><prevent><preventing><promoting health><racial minority><randomized control trial><recruit><reduce risk><reduce risks><reduce that risk><reduce the risk><reduce these risks><reduces risk><reduces the risk><reducing risk><reducing the risk><risk-reducing><severe acute respiratory syndrome coronavirus 2 associated death><severe acute respiratory syndrome coronavirus 2 associated fatality><severe acute respiratory syndrome coronavirus 2 associated mortality><severe acute respiratory syndrome coronavirus 2 death><severe acute respiratory syndrome coronavirus 2 fatality><severe acute respiratory syndrome coronavirus 2 induced death><severe acute respiratory syndrome coronavirus 2 induced fatality><severe acute respiratory syndrome coronavirus 2 induced mortality><severe acute respiratory syndrome coronavirus 2 mortality><severe acute respiratory syndrome coronavirus 2 related death><severe acute respiratory syndrome coronavirus 2 related fatality><severe acute respiratory syndrome coronavirus 2 related mortality><social norm><theories><tool><two arm RCT><two arm randomized control trial><two arm randomized controlled trial><vaccinate against COVID-19><vaccinate against COVID19><vaccinate against SARS-CoV-2><vaccinate against coronavirus disease 2019><vaccinate against severe acute respiratory syndrome coronavirus 2><vaccination acceptability><vaccination acceptance><vaccination access><vaccination against COVID-19><vaccination against COVID19><vaccination against SARS-CoV-2><vaccination against Severe acute respiratory syndrome coronavirus 2><vaccination against coronavirus disease 2019><vaccination availability><vaccination confidence><vaccination hesitancy><vaccination uptake><vaccination willingness><vaccine acceptability><vaccine acceptance><vaccine access><vaccine against 2019-nCov><vaccine against SARS-CoV-2><vaccine against SARS-CoV2><vaccine against SARS-coronavirus-2><vaccine against Severe Acute Respiratory Syndrome CoV 2><vaccine against Severe acute respiratory syndrome coronavirus 2><vaccine availability><vaccine confidence><vaccine for novel coronavirus><vaccine hesitancy><vaccine hesitant><vaccine uptake><vaccine willingness><wart virus><web based><willingness><youngster>